HBM HEALTHCARE INVESTMENTS AG

(HBMN)
  Report
Delayed Swiss Exchange  -  11:31 2022-06-29 am EDT
272.00 CHF   -0.18%
06/17Key Figures 15.06.2022
EQ
06/10Shareholders' Meeting of HBM Healthcare Investments approved all proposals by the Board of Directors
EQ
06/10HBM Healthcare Investments AG Approves Distribution, Payable on 1 September 2022
CI
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

HBM Healthcare Investments Sees 3% Drop in April NAV

05/02/2022 | 11:01pm EDT


© MT Newswires 2022
All news about HBM HEALTHCARE INVESTMENTS AG
06/17Key Figures 15.06.2022
EQ
06/10Shareholders' Meeting of HBM Healthcare Investments approved all proposals by the Board..
EQ
06/10HBM Healthcare Investments AG Approves Distribution, Payable on 1 September 2022
CI
06/03Bristol Myers Squibb to Acquire HBM Portfolio Company Turning Point Therapeutics for US..
EQ
06/01HBM HEALTHCARE INVESTMENTS : Key Figures 31.05.2022
PU
06/01Key Figures 31.05.2022
EQ
05/18HBM Healthcare Investments AG Reports Earnings Results for the Full Year Ended March 31..
CI
05/18Publication of Annual Report 2021/2022 and Invitation to the Ordinary Shareholders? Mee..
EQ
05/16Key Figures 15.05.2022
EQ
05/10Pfizer to acquire HBM portfolio company Biohaven Pharmaceuticals in USD 11.6 billion de..
EQ
More news
Analyst Recommendations on HBM HEALTHCARE INVESTMENTS AG
More recommendations
Financials
Sales 2023 170 M 178 M 178 M
Net income 2023 122 M 128 M 128 M
Net cash 2023 35,0 M 36,7 M 36,7 M
P/E ratio 2023 15,5x
Yield 2023 3,57%
Capitalization 1 892 M 1 984 M 1 984 M
EV / Sales 2023 10,9x
EV / Sales 2024 7,56x
Nbr of Employees 700
Free-Float 82,7%
Chart HBM HEALTHCARE INVESTMENTS AG
Duration : Period :
HBM Healthcare Investments AG Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends HBM HEALTHCARE INVESTMENTS AG
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 1
Last Close Price 272,00 CHF
Average target price 292,00 CHF
Spread / Average Target 7,35%
EPS Revisions
Managers and Directors
Andreas Wicki Chief Executive Officer
Erwin Troxler Chief Financial Officer
Hans-Peter Hasler Chairman
Rudolf Lanz Director
Mario Germano Giuliani Director